Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
12/12/1996 | WO1996039397A1 Benzisoxazole and indazole derivatives as antipsychotic agents |
12/12/1996 | WO1996039383A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists |
12/12/1996 | WO1996039382A1 Urea derivatives as 5-ht antagonists |
12/12/1996 | WO1996039372A2 Macrophage lipid chemoattractant |
12/12/1996 | WO1996039224A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
12/12/1996 | WO1996039223A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
12/12/1996 | WO1996039222A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
12/12/1996 | WO1996039194A1 Novel cathepsin and methods and compositions for inhibition thereof |
12/12/1996 | WO1996039154A1 Oligonucleotides having phosphorothioate linkages of high chiral purity |
12/12/1996 | WO1996039136A1 Transdermal formulation comprising ropinirole |
12/12/1996 | CA2223957A1 Transforming growth factor alpha hi |
12/12/1996 | CA2223307A1 Amino-substituted thiadiazoles, pyrimidines, triazines or triazoles useful as ctf receptor antagonists |
12/12/1996 | CA2223239A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists |
12/12/1996 | CA2223103A1 Oligonucleotides having phosphorothioate linkages of high chiral purity |
12/12/1996 | CA2222040A1 Macrophage lipid chemoattractant |
12/12/1996 | CA2221684A1 Novel cathepsin and methods and compositions for inhibition thereof |
12/12/1996 | CA2221637A1 Human g-protein receptor hcegh45 |
12/12/1996 | CA2221258A1 Use of neuro-derived fetal cell lines for transplantation therapy |
12/12/1996 | CA2218329A1 Fibroblast growth factor-11 |
12/12/1996 | CA2217301A1 Fibroblast growth factor 15 |
12/11/1996 | EP0747379A1 Derivatives of indole, indazole and benzisoxazole for the treatment of schizophrenia |
12/11/1996 | EP0747378A1 Dihydropyridine NPY antagonists |
12/11/1996 | EP0747357A2 Dihydropyridine NPY antagonists: piperidine derivatives |
12/11/1996 | EP0747356A1 Dihydropyridine NPY antagonists: piperazine derivatives |
12/11/1996 | EP0747354A1 3-Substituted oxindole derivatives as potassium channel modulators |
12/11/1996 | EP0747353A2 Indole derivatives |
12/11/1996 | EP0747346A2 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
12/11/1996 | EP0747345A2 Ethylamido fluorenes and improved method of making same |
12/11/1996 | EP0747033A1 Transfusion liquid-containing holder and prepared transfusion liquid |
12/11/1996 | EP0746567A1 Novel opioid peptides for the treatment of pain and use thereof |
12/11/1996 | EP0746566A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
12/11/1996 | EP0746557A1 Intracellular signalling mediators |
12/11/1996 | EP0746556A1 Tricyclic compounds having affinity for the 5-ht1a receptor |
12/11/1996 | EP0746549A1 Acetic acid amide derivatives and process for the preparation thereof |
12/11/1996 | EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
12/11/1996 | EP0746324A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds |
12/11/1996 | EP0746323A1 Inhibitors of phosphoinositide-specific phospholipase c |
12/11/1996 | EP0746322A1 Treatment of alzheimer's disease and modulation of immune system with delta5-androstenes |
12/11/1996 | EP0746317A1 Sublingual or buccal pharmaceutical composition |
12/11/1996 | EP0746316A1 Therapeutic guanidines |
12/11/1996 | EP0746202A1 Pharmaceutically active antioxydant containing composition and the method of its use to prevent and treat restenosis following angioplasty |
12/11/1996 | EP0607163B1 NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2-a]PYRAZINES |
12/11/1996 | EP0498890B1 Central nervous system activator |
12/11/1996 | CN1137793A 6-(2-imidzolinylamino) quinoline compounds useful as alpha-2 adrenoceptor agonists |
12/11/1996 | CN1137753A Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
12/11/1996 | CN1137752A DI-tert-butylphenol compounds useful as anti-inflammatory agents |
12/10/1996 | US5583221 Antiinflammatory agents, cardiovascular disorders, viricides, fungicides |
12/10/1996 | US5583159 Treatment of internal radiation damage |
12/10/1996 | US5583149 Treating vascular headaches |
12/10/1996 | US5583145 Psychological disorders |
12/10/1996 | US5583142 Analgesic and nootropic drugs |
12/10/1996 | US5583141 Heterocyclic compounds and their use as angiotensin antagonists |
12/10/1996 | US5583117 Acylated uridine and cytidine for elevating tissue uridine and cytidine |
12/10/1996 | US5582823 Methods of treating bacterial inflammation and granulocytopoiesis by administering human pluripotent granulocyte colony-stimulating factor |
12/10/1996 | CA1338789C 3,4-disubstituted phenyl heterocycles and their use |
12/10/1996 | CA1338779C Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics |
12/08/1996 | CA2178414A1 Dihydropyridine npy antagonists: nitrogen heterocyclic derivatives |
12/08/1996 | CA2178413A1 Dihydropyridine npy antagonists: piperazine derivatives |
12/08/1996 | CA2177110A1 Dihydropyridine npy antagonists: piperidine derivatives |
12/08/1996 | CA2176854A1 N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics |
12/05/1996 | WO1996038457A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
12/05/1996 | WO1996038444A1 Oxazolidinone derivatives, their preparation and therapeutical use |
12/05/1996 | WO1996038439A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them |
12/05/1996 | WO1996038431A1 Process for making heterocyclic compounds |
12/05/1996 | WO1996038430A1 Process for making heterocyclic compounds |
12/05/1996 | WO1996038414A1 Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
12/05/1996 | WO1996038151A1 Method for treating cognitive dysfunction |
12/05/1996 | WO1996038142A1 1h-4(5)-substituted imidazole derivatives |
12/05/1996 | WO1996038139A1 Use of pyrrolidine derivatives for treating alcoholism |
12/05/1996 | WO1996034099A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
12/05/1996 | CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
12/05/1996 | CA2222179A1 Process for making heterocyclic compounds |
12/05/1996 | CA2222099A1 1h-4(5)-substituted imidazole derivatives |
12/05/1996 | CA2222033A1 Process for making heterocyclic compounds |
12/05/1996 | CA2196425A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them |
12/04/1996 | EP0745601A1 Process for preparing 1,2,5-thiadiazole derivatives |
12/04/1996 | EP0745598A1 Piperazine, piperidine and 1,2,5,6-tetrahydropyridine derivatives, proces for their preparation and pharmaceutical compositions containing them |
12/04/1996 | EP0745597A2 Novel melatonergic indanyl piperazines or homopiperazines |
12/04/1996 | EP0745596A1 Heteroaromatic oxazole compounds and use thereof |
12/04/1996 | EP0745591A1 Indanylpiperidines as melatonergic agents |
12/04/1996 | EP0745586A1 Aryl(alkyl) propylamides, process for their preparation and pharmaceutical compositions containing them |
12/04/1996 | EP0745584A1 Arylalkyl(thio) carboxamides compounds with affinity for melatonine receptors, processes for their preparation and pharmaceutical compositions containing them |
12/04/1996 | EP0745583A1 Alkoxy aryl compounds with affinity to the melatonine receptors, process for their preparation and pharmaceutical compositions containing them |
12/04/1996 | EP0745122A1 Galanin receptor, nucleic acids, transformed cells and uses thereof |
12/04/1996 | EP0745093A1 New oligopeptides with affinity to opioid receptors |
12/04/1996 | EP0745081A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
12/04/1996 | EP0745080A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
12/04/1996 | EP0745079A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists |
12/04/1996 | EP0744954A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
12/04/1996 | EP0744944A1 Sexual steroid-containing transdermal therapeutic systems |
12/04/1996 | EP0744943A1 Desogestrel-containing transdermal application agent |
12/04/1996 | CN1137267A N,N'-bis (2-hydroxybenzyl) ethylenediamine-N,N'-diacetic acid derivatives as chelating agents |
12/04/1996 | CN1137236A Paroxetine tablets and process to prepare them |
12/04/1996 | CN1137039A Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz (b,f) oxepines |
12/04/1996 | CN1137036A Benzonitriles and benzofluorides |
12/04/1996 | CN1136960A Polyamines and polypeptides useful as antagonisis of excitatory amino acid neurotransmitiers and/or as blockers of calcium channels |
12/04/1996 | CN1136921A Pharmaceutical agents for treatment of alzheimer's disease |
12/04/1996 | CN1136920A Use of benzopyran derivatives for production of pharmaceutical compositions |
12/04/1996 | CN1033454C Process for preparing 4-|(2-benzothiazolyl) methylamino¨-alpha-|(3,4-difluorophinoxy) methyl¨-1-piperidineethanol |
12/03/1996 | US5580987 Process for preparing 1-aminoacetamidopyrroles |